Seleno-Auranofin (Et3PAuSe-tagl): Synthesis, Spectroscopic (EXAFS, 197Au Mössbauer, 31P, 1H, 13C, and 77Se NMR, ESI-MS) Characterization, Biological Activity, and Rapid Serum Albumin-Induced Triethylphosphine Oxide Generation
- 12 August 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Inorganic Chemistry
- Vol. 49 (17), 7663-7675
- https://doi.org/10.1021/ic902335z
Abstract
Seleno-auranofin (SeAF), an analogue of auranofin (AF), the orally active antiarthritic gold drug in clinical use, was synthesized and has been characterized by an array of physical techniques and biological assays. The Mössbauer and extended X-ray absorption fine structure (EXAFS) parameters of the solid compound demonstrate a linear P-Au-Se coordination environment at a gold(I) center, analogous to the structure of auranofin. The (31)P, (13)C, and (1)H NMR spectra of SeAF in chloroform solution closely resemble those of auranofin. The (77)Se spectrum consists of a singlet at 481 ppm, consistent with a metal-bound selenolate ligand. The absence of (2)J(PSe) coupling in the (31)P and (77)Se spectra may arise from dynamic processes occurring in solution or because the (2)J(PSe) coupling constants are smaller than the observed bandwidths. Electrospray ionization mass spectrometry (ESI-MS) spectra of SeAF in 50:50 methanol-water exhibited strong signals for [(Et(3)P)(2)Au](+), [(Et(3)PAu)(2)-mu-Se-tagl](+), and [Au(Se-tagl)(2)](-), which arise from ligand scrambling reactions. Three assays of the anti-inflammatory activity of SeAF allowed comparison to AF. SeAF exhibited comparable activity in the topically administered murine arachadonic acid-induced and phorbol ester-induced anti-inflammatory assays but was inactive in the orally administered carrageenan-induced assay in rats. However, in vivo serum gold levels were comparable in the rat, suggesting that differences between the in vivo metabolism of the two compounds, leading to differences in transport to the inflamed site, may account for the differential activity in the carrageenan-induced assay. Reactions of serum albumin, the principal transport protein of gold in the serum, demonstrated formation of AlbSAuPEt(3) at cysteine 34 and provided evidence for facile reduction of disulfide bonds at cysteine 34 and very rapid formation of Et(3)P=O, a known metabolite of auranofin.This publication has 83 references indexed in Scilit:
- Inhibition of Schistosoma mansoni Thioredoxin-glutathione Reductase by AuranofinOnline Journal of Public Health Informatics, 2009
- Inhibition of Selenium Metabolism in the Oral Pathogen Treponema denticolaJournal of Bacteriology, 2009
- No Selenium Required: Reactions Catalyzed by Mammalian Thioredoxin Reductase That Are Independent of a Selenocysteine ResidueBiochemistry, 2009
- Auranofin disrupts selenium metabolism in Clostridium difficile by forming a stable Au–Se adductJBIC Journal of Biological Inorganic Chemistry, 2009
- Arsenic trioxide and auranofin inhibit selenoprotein synthesis: implications for chemotherapy for acute promyelocytic leukaemiaBritish Journal of Pharmacology, 2008
- Platyhelminth Mitochondrial and Cytosolic Redox Homeostasis Is Controlled by a Single Thioredoxin Glutathione Reductase and Dependent on Selenium and GlutathioneOnline Journal of Public Health Informatics, 2008
- Selenium metabolism in Trypanosoma: characterization of selenoproteomes and identification of a Kinetoplastida-specific selenoproteinNucleic Acids Research, 2006
- Self-Assembly of [(Me2PhP)2Au]+[Au(GeCl3)2]- into Linear Ion Quadruples with an Unusual [+ − − +] SequenceJournal of the American Chemical Society, 1996
- Topical auranofin ointment for the treatment of plaque psoriasisJournal of the American Academy of Dermatology, 1995
- Lithium-(2,4,6-tri-tert-butylphenylselenid); Erzeugung, Struktur und Reaktionen unter Knüpfung von Se –P-, Se – C-, Se – Si-, Se – Sn- und Se – Au-BindungenEuropean Journal of Inorganic Chemistry, 1991